Development of the Human Lung
|
|
|
Peter Rothstein, MD |
|
Professor of Clinical Anesthesiology
and Clinical Pediatrics |
|
(Retired) |
|
|
Learning Objectives:
|
|
|
Understand the growth and functional
development of the respiratory system |
|
Identify the stages of lung development
and the major events of each stage |
|
Understand the physical and biochemical
requirements for alveolar development and function |
|
Identify the developmental causes of
neonatal respiratory failure, tracheoesophageal fistula and diaphragmatic
hernia |
Phases of Lung Development
|
|
|
|
Lung Growth |
|
Structural development |
|
Anatomic development |
|
Affected by physical factors |
|
Lung Maturation |
|
Functional development |
|
Biochemical development |
|
Affected by hormonal factors |
Slide 4
Slide 5
Slide 6
Slide 7
Derivation of lung elements
|
|
|
Lung buds lined by endodermally derived
epithelium—differentiates into respiratory epithelium, which lines airways
and specialized epithelium that lines the alveoli |
|
Ectoderm-contributes to innervation |
|
Mesoderm- blood vessels, smooth muscle,
cartilage and other connective tissue |
Slide 9
"The pseudoglandular stage
takes place..."
|
|
|
The pseudoglandular stage takes place
between the 7th and 16th week of embryonic development |
Slide 11
"For branching to
occur,"
|
|
|
For branching to occur, bronchial
mesoderm is required. |
|
The rate and extent of branching is
proportional to the amount of mesenchyme present. |
|
After 16 weeks, further growth occurs
by branching and elongation. |
"Cilia appear in the
proximal..."
|
|
|
Cilia appear in the proximal airways by
13 weeks. |
|
There is a transition from bronchial
epithelial cells (ciliated and columnar cells) to alveolar Type II cells. |
"Mesenchyme is
necessary for epithelial..."
|
|
|
Mesenchyme is necessary for epithelial
differentiation to occur. |
|
Differentiation of mesenchyme requires
the presence of lung epithelium. |
Canalicular Period 16-26 wk
|
|
|
By 20 weeks the alveolar Type 1 cell is
present |
|
Lamellar bodies start to appear in Type
2 cells |
Terminal Sac Period 26 wk →
|
|
|
Surfactant appears in lamellar bodies
of Type 2 cells. |
|
Stability of the lung at birth
correlates with the number of lamellar bodies present. |
"By 20 weeks,"
|
|
|
By 20 weeks, the alveolar Type 1 cell
is present. |
|
Lamellar bodies start to appear in Type
2 cells. |
Primitive Saccule
|
|
|
Approximately 20 x 106
saccules present at birth. |
Postnatal stage
|
|
|
“Adult” configuration reached by 5
weeks. |
Slide 20
Characteristics of Mature
Alveolus
|
|
|
Connected to alveolar duct |
|
Lined with Type 1 cells, which are in
intimate contact with capillaries |
|
Each capillary is exposed to 2 alveoli |
|
Contains surfactant |
|
Has interconnections with adjacent
alveoli through pores of Kohn. |
Slide 22
Slide 23
Slide 24
Development of Pulmonary
Arterial Muscle
Control of Pulmonary Blood
Flow
|
|
|
Physical Location of Lung Unit |
|
Gravity |
|
Oxygen |
|
Nitric oxide |
Hypoxic Pulmonary
Vasoconstriction
Physical Influences on Lung
Growth
Slide 29
Physical Influences on Lung
Growth
|
|
|
|
Amniotic fluid |
|
Oligohydramnios→Potters syndrome |
Physical Influences on Lung
Growth
|
|
|
Congenital diaphragmatic hernia |
|
Musculoskeletal abnormalities of the
chest wall |
|
Space occupying lesions of the thorax,
e.g. pleural effusions |
|
Oligohydramnios associated with renal
or urinary tract abnormalities |
Slide 32
Slide 33
Slide 34
Slide 35
Hormonal Influence on the
Lung
|
|
|
Corticotropin stimulates cortisol |
|
Cortisol stimulates fetal lung
fibroblast to produce fibroblast pneumocyte factor, which, |
|
Stimulates surfactant production in
Type 2 cells |
|
Thyroid hormone is also necessary for
surfactant production |
Hormonal Influence on the
Lung
|
|
|
At birth, epinephrine and arginine
vasopressin suppress fetal lung fluid production and play a role in its
reabsorption |
Slide 38
Slide 39
The Problem of Prematurity
|
|
|
Birth before 36 weeks may be associated
with respiratory compromise and failure. |
|
80,000 cases/yr of neonatal respiratory
failure |
|
8,500 deaths |
|
CNS injury in survivors |
|
Cost = $4.4 billion/yr |
Slide 41
Slide 42
Slide 43
Neonatal Respiratory
Failure
|
|
|
|
Incidence |
|
20/1000 boys |
|
15.6/1000 girls |
|
29/1000 blacks |
The lung is ignored only at
your own peril!
DON’T HOLD YOUR BREATH!